{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-133773","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.063764+00:00","generated_at":"2026-05-20T01:52:38.685520+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Xilio Therapeutics prices $50M public offering of warrants; cash runway through Q3 2026","bullets":["Net proceeds of ~$46.6M from offering of pre-funded warrants and Series A/B/C warrants, priced at $0.7499 per unit.","Cash runway extended to Q3 2026, assuming no contributions from AbbVie or Gilead partnerships.","Series A warrants exercisable after Dec 1, 2025 or if stock closes above $1.50 for five days; $0.75 exercise price.","Series B and C warrants subject to offset/cancellation if non-dilutive capital ≥$20M received before Dec 1, 2026.","If all Series B and C warrants exercised for cash, additional gross proceeds up to ~$100M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-133773","json":"https://secwatch.observer/filing/0001193125-25-133773.json","markdown":"https://secwatch.observer/filing/0001193125-25-133773.md","text":"https://secwatch.observer/filing/0001193125-25-133773.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000119312525133773/0001193125-25-133773-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000119312525133773/d88500d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:52:38.685520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}